JESSICA MARCHANT: Open Payments
NPI 1083240568 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$774 in 35 payments from 17 companies in 2025. Trend: 2023 $125 · 2024 $263 · 2025 $774
Food & beverage: $774
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 4 | $121 |
| Insmed, Inc. | 4 | $91 |
| ABBVIE INC. | 4 | $75 |
| SANOFI-AVENTIS U.S. LLC | 3 | $70 |
| Paratek Pharmaceuticals, Inc. | 3 | $66 |
| Novo Nordisk Inc | 3 | $58 |
| Merck Sharp & Dohme LLC | 2 | $55 |
| PFIZER INC. | 2 | $43 |
| Lilly USA, LLC | 2 | $35 |
| Aimmune Therapeutics, Inc. | 1 | $28 |
Products named: CABENUVA, Arikayce, TZIELD, NUZYRA, Wegovy, PREVYMIS, QULIPTA, MOUNJARO.
Industry payments across TX — which companies pay providers there.
